CorMedix Announces $75 Mln Share Buyback Program

February 02, 2026 — 08:55 am EST

Written by RTTNews.com for RTTNews

(RTTNews) - CorMedix Therapeutics (CRMD) said Monday that its Board has approved a share repurchase program of up to $75 million through December 31, 2027.

"With a strong balance sheet, solid operating performance, and expected ongoing cash flow generation, we believe we are well positioned to execute this share repurchase program while continuing to advance our growth strategy," said Joseph Todisco, Chairman & CEO of CorMedix Therapeutics.

The company expects to begin repurchasing shares as early as the first quarter of 2026.

As of December 31, 2025, CorMedix had approximately $150 million in cash and cash equivalents and 79.3 million shares outstanding.

CorMedix shares were up more than 2% in pre-market trading after closing at $7.76, up 3.24% on Friday.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

CorMedix Announces $75 Mln Share Buyback Program

Tags

Latest Articles